Axogen, Inc. (LON:0HKD)
18.14
+0.28 (1.57%)
At close: Oct 24, 2025
Axogen Revenue
Axogen had revenue of $56.66M USD in the quarter ending June 30, 2025, with 18.26% growth. This brings the company's revenue in the last twelve months to $203.27M, up 17.17% year-over-year. In the year 2024, Axogen had annual revenue of $187.34M with 17.81% growth.
Revenue (ttm)
$203.27M
Revenue Growth
+17.17%
P/S Ratio
4.13
Revenue / Employee
$449.71K
Employees
452
Market Cap
613.36M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 187.34M | 28.33M | 17.81% |
| Dec 31, 2023 | 159.01M | 20.43M | 14.74% |
| Dec 31, 2022 | 138.58M | 11.23M | 8.81% |
| Dec 31, 2021 | 127.36M | 15.06M | 13.41% |
| Dec 31, 2020 | 112.30M | 5.59M | 5.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 31.63B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
Axogen News
- 4 days ago - Insider Sell Alert: Burke William P. Mr. Sells 1,457 Shares of Axogen Inc (AXGN) - GuruFocus
- 10 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN - PRNewsWire
- 15 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN - PRNewsWire
- 20 days ago - Insider Sell: Burke William P. Mr. Sells Shares of Axogen Inc (AXGN) - GuruFocus
- 25 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN - PRNewsWire
- 27 days ago - Axogen, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – AXGN - Business Wire
- 27 days ago - AXGN Investors Have Opportunity to Join Axogen, Inc. Fraud Investigation with the Schall Law Firm - Business Wire
- 4 weeks ago - AXGN: HC Wainwright & Co. Initiates Coverage With Buy Rating | AXGN Stock News - GuruFocus